| Company Name | Fiscal Year | EPS (Actual) | EPS (Estimated) | Revenue (Actual) | Revenue (Estimated) | Exchange | |||
|---|---|---|---|---|---|---|---|---|---|
| Loading past events... | |||||||||
|
Thursday - Sep 24, 2009 |
|||||||||
|
Steelcase
SCS
|
Q2 FY10 | $0.09 | - | $2.29B | $3.64B |
NYSE |
|||
| Q3 FY09 | $0.28 | $0.27 | $791.70M | $750.03M |
NYSE |
||||
|
Scholastic
SCHL
|
Q1 FY10 | -$0.70 | -$0.83 | $315.60M | $374.21M |
NASDAQ |
|||
|
Vail Resorts
MTN
|
Q4 FY09 | -$1.07 | -$1.09 | $101.93M | $103.83M |
NYSE |
|||
|
Neogen
NEOG
|
Q1 FY10 | $0.05 | $0.04 | $32.35M | $29.11M |
NASDAQ |
|||
|
Northeast Bank
NBN
|
- | $0.19 | - | $10.66M | - |
NASDAQ |
|||
|
Perspective Therapeutics
CATX
|
- | -$0.06 | -$0.04 | $1.21M | $806.67K |
AMEX |
|||
|
ADMA Biologics
ADMA
|
- | -$8.00 | - | - | - |
NASDAQ |
|||
